FDA NDA · NDA009667

RESERPINE

Sponsor: VALEANT PHARM INTL

APPLICATION

NDA009667

TYPE

NDA

LATEST ACTION

1979-10-18

ROUTE

ORAL

DOSAGE FORM

TABLET

MARKETING STATUS

Discontinued

Products

RESERPINEDiscontinued

RESERPINE 0.1MG · TABLET · ORAL

RESERPINEDiscontinued

RESERPINE 0.25MG · TABLET · ORAL

1979-10-18Labeling · Supplement 18AP

1979-09-12Manufacturing (CMC) · Supplement 16 · standardAP

1976-12-07Labeling · Supplement 15AP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.